Increased percentage of L-selectin+ and ICAM-1+ peripheral blood CD4+/CD8+ T cells in active Graves' ophthalmopathy

Folia Histochemica et Cytobiologica

Volumn 47, Issue 1, 2009, Pages 29-33

  Pawlowski, Przemysław ^a   Mysliwiec, Janusz ^a   Stasiak Barmuta, Anna ^a   Bakunowicz Lazarczyk, Alina ^a   Gorska, Maria ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Graves' ophthalmopathy; ICAM 1; L selectin; T lymphocytes subsets

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; THYROTROPIN RECEPTOR ANTIBODY;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENDOCRINE OPHTHALMOPATHY; FEMALE; GRAVES DISEASE; HUMAN; INFLAMMATION; MALE; VOLUNTEER;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; FEMALE; GRAVES OPHTHALMOPATHY; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; L-SELECTIN; MALE; RECEPTORS, THYROTROPIN;

EID: 66449125557     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-009-0020-4     Document Type: Article

References (21)

1. Boulos PR, Hardy I. Thyroid-associated orbitopathy: a clinicopathological and therapeutic review. Curr Opin Ophthalmology. 2004;15:389-400.
2. Kazim M, Goldberg RA, Smith TJ. Insights into the pathogenesis of thyroid associated orbitopathy. Arch Ophthalmology. 2002;120:380-386.
3. Bartalena L, Wiersunga WM, Pinchera A. Graves' ophthalmopathy: state of the art and perspectives. J Endorinol Invest. 2004;27:295-301.
4. Wakelkamp IM, Bakker O, Baldeschi L, Wiersinga WM, Prummel MF. TSH-R expression and cytokine profile in orbital tissue of active vs inactive Graves's ophthalmopathy patients. Clin Endocrinol (Oxf). 2003;58:280-287.
5. Bahn RS. Thyrotropin receptor expression in Orbital Adipose/Connective Tissues from Patients with Thyroid-Associated Ophthalmopathy. Thyroid. 2002;12:193-195.
6. Heufelder AE. Pathogenesis of ophthalmopathy in autoimmune thyroid disease. Rev Endocr Metab Disord. 2000;1:87-95.
7. Yan SX, Wang Y. Inhibitory effects of Triptolide on interferon-gamma-induced human leucocyte antigen-DR, intercellular adhesion molecule-1, CD40 expression on retro-ocular fibroblasts derived from patients with Graves' ophthalmopathy. Clin Experimental Ophthalmology. 2006;34:265-71.
8. Pappa A, Calder V, Ajjan R, et al. Adhesion molecules expression in vivo on extraocular muscles (EOM) in thyroidassociated ophthalmopathy (GO). Clin Experimental Immunol. 1997;108:309-313.
9. Kulig G, Pilarska K, Kulig J, Krzyzanowska-Swiniarska B, Andrysiak-Mamos E, Robaczyk M. Magnetic resonance imaging and soluble forms of adhesion molecules: sICAM and sVCAM in assessing the activity of thyroid orbitopathy. Pol Arch Med Wewn. 2004;111:161-9.
10. Mysliwiec J, Kretowski A, Szelachowska M, Topolska J, Mikita A, Kinalska I. Serum L-selectin and ICAM-1 in patients with Graves' ophthalmopathy during treatment with corticosteroids. Immunol Letters. 2001;78:123-126.
11. Kretowski A, Wawrusiewicz N, Mironczuk K, Mysliwiec J, Kretowska M, Kinalska I. Intercellular adhesion molecule 1 gene polymorphisms in Graves' disease. J Clin Endocrinol Metab. 2003;88:4945-9.
12. Wiersinga WM, Perros P, Kahaly GJ, et al. Clinical assessment of patients with Graves' Orbitopathy: The European Group on Graves' Orbitopathy (EUGOGO) recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol. 2006;155:207-2011.
13. De Bellis A, Di Martino S, Fiordelisi F, et al. Soluble intercellular adhesion molecule-1 (sICAM-1) concentrations in Graves's disease patients followed up for development of ophthalmopathy. J Clin Endocrinol Metab. 1998;83:1222-5.
14. Wakelkamp IM, Gerding MN, van der Meer JW, Prummel MF, Wiersinga WM. Smoking and disease severity are independent determinants of serum adhesion molecule levels in Graves' ophthalmopathy. Clin Exp Immunol. 2002;127:316-20.
15. Bossowski A, Urban M, Stasiak-Barmuta A, Turowski D. Expression of Very Late Antigen-4 and Lymphocyte Function-Associates Antigen-1 on Peripheral Blood Lymphocytes from Patients with Graves Disease. Pediatr Res. 2002;52:533-7.
16. Pappa A, Lawson JM, Calder V, Fells P, Lightman S. T cells and fibroblasts in affected extraocular muscles in early and late thyroid associated ophthalmopathy. Br J Ophthalmol. 2000;84:517-522.
17. Foerster G, Otto E, Hansen C, Ochs K, Kahaly G. Analysis of orbital T cells in thyroid-associated ophthalmopathy. Clin Exp Immunol. 1998;112:427-434.
18. Aniszewski JP, Valyasevi RW, Bahn RS. Relationship between disease duration and predominant orbital T cell subset in Graves's ophthalmopathy. J Clin Endocrinol Metab. 2000;85:776-780.
19. Xia N, Zhou S, Liang Y et al. CD4+ T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy. Int J Mol Med. 2006;17:911-6.
20. Liu GQ, Wu ZY, Yang HS, Zheng JL, Lin Z. The inhibition effect of interleukin-1 alpha-induced intercellular adhesion molecule-1 expression on orbital fibroblasts and adhesion of peripheral blood mononuclear cells. Zhonghua Yan Ke Za Zhi. 2003;39:528-32.
21. Modelska-Ziolkiewicz A, Gembicki M, Bednarek J, Sowinski J. Prognostic role of adhesion molecules sELAM-1 and sICAM-1 in glucocorticoid therapy of active ophthalmopathy. Pol Arch Med Wewn. 2003;109:469-75.